Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 31, 1999

Study Completion Date

October 31, 2000

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Inhaled human insulin

Trial Locations (35)

Unknown

Pfizer Investigational Site, Duarte

Pfizer Investigational Site, Long Beach

Pfizer Investigational Site, Los Angeles

Pfizer Investigational Site, Stanford

Pfizer Investigational Site, Denver

Pfizer Investigational Site, New Haven

Pfizer Investigational Site, Gainesville

Pfizer Investigational Site, Hollywood

Pfizer Investigational Site, Miami

Pfizer Investigational Site, Tallahassee

Pfizer Investigational Site, Peoria

Pfizer Investigational Site, Skokie

Pfizer Investigational Site, Lutherville

Pfizer Investigational Site, Waltham

Pfizer Investigational Site, Minneapolis

Pfizer Investigational Site, Columbia

Pfizer Investigational Site, New Hyde Park

Pfizer Investigational Site, Rochester

Pfizer Investigational Site, Syracuse

Pfizer Investigational Site, The Bronx

Pfizer Investigational Site, Durham

Pfizer Investigational Site, Winston-Salem

Pfizer Investigational Site, Portland

Pfizer Investigational Site, Pittsburgh

Pfizer Investigational Site, Dallas

Pfizer Investigational Site, Houston

Pfizer Investigational Site, Burlington

Pfizer Investigational Site, Charlottesville

Pfizer Investigational Site, Charlottsville

Pfizer Investigational Site, Seattle

Pfizer Investigational Site, Edmonton

Pfizer Investigational Site, Hamilton

Pfizer Investigational Site, Mississauga

Pfizer Investigational Site, Toronto

Pfizer Investigational Site, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY